Hernane, Baby Girl M.

HRN: 21-40-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/23/2022
05/30/2022
IVT
38 Mg
24 Hrs
Neonatal Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: